Figure 3.
Figure 3. Serum cytokines and CRP levels in subjects developing toxicities. (A) IFN-γ (IFN-g), (B) IL-10, (C) IL-6, and (D) CRP concentrations increase after infusion of CAR T cells (2 days following ASCT) in all patients. Both IFN-γ and IL-10 increased significantly at day 5 post-ASCT in subjects developing a neurotoxicity plus or minus CRS than in subjects without toxicities (P < .001 and P = .07, respectively). There was a trend for significant increase of IL-6 concentration in subjects with CRS than in subjects without CRS. Increases in CRP levels were similar in subjects with and without toxicities.

Serum cytokines and CRP levels in subjects developing toxicities. (A) IFN-γ (IFN-g), (B) IL-10, (C) IL-6, and (D) CRP concentrations increase after infusion of CAR T cells (2 days following ASCT) in all patients. Both IFN-γ and IL-10 increased significantly at day 5 post-ASCT in subjects developing a neurotoxicity plus or minus CRS than in subjects without toxicities (P < .001 and P = .07, respectively). There was a trend for significant increase of IL-6 concentration in subjects with CRS than in subjects without CRS. Increases in CRP levels were similar in subjects with and without toxicities.

Close Modal

or Create an Account

Close Modal
Close Modal